
BioAtla, Inc. Common Stock
BCAB Real Time Price USDRecent trades of BCAB by members of U.S. Congress
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by BCAB's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
BCAB Revenue by Segment or Geography

No Revenue by Segment data for this ticker

No Revenue by Geography data for this ticker
New patents grants
-
Patent Title: Conditionally active biological proteins Oct. 08, 2024
-
Patent Title: Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts May. 07, 2024
-
Patent Title: Anti-axl antibodies, antibody fragments and their immunoconjugates and uses thereof Feb. 13, 2024
-
Patent Title: Anti-ror2 antibodies, antibody fragments, their immunoconjucates and uses thereof Jan. 23, 2024
-
Patent Title: Conditionally active anti-epcam antibodies, antibody fragments, their immunoconjugates and uses thereof Dec. 26, 2023
-
Patent Title: Anti-il-22 antibodies, antibody fragments, their immunoconjugates and uses thereof Dec. 05, 2023
-
Patent Title: Conditionally active polypeptides and methods of generating them Oct. 03, 2023
-
Patent Title: Mirac proteins Aug. 08, 2023
-
Patent Title: Methods of protein evolution May. 02, 2023
-
Patent Title: Conditionally active chimeric antigen receptors for modified t-cells Feb. 21, 2023
-
Patent Title: Anti-ctla4 antibodies, antibody fragments, their immunoconjugates and uses thereof Jan. 03, 2023
-
Patent Title: Conditionally active polypeptides Oct. 18, 2022
-
Patent Title: Comprehensive monoclonal antibody generation Jul. 26, 2022
-
Patent Title: Express humanization of antibodies Jul. 26, 2022
-
Patent Title: Proteins targeting orthologs Apr. 05, 2022
-
Patent Title: Conditionally active polypeptides and methods of generating them Mar. 22, 2022
-
Patent Title: Conditionally active biological proteins Feb. 22, 2022
-
Patent Title: Anti-ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof Feb. 22, 2022
-
Patent Title: Anti-axl antibodies, antibody fragments and their immunoconjugates and uses thereof Oct. 19, 2021
-
Patent Title: Conditionally active chimeric antigen receptors for modified t-cells Sep. 07, 2021
-
Patent Title: Modified antibody regions and uses thereof Mar. 23, 2021
-
Patent Title: Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts Feb. 16, 2021
-
Patent Title: Methods of protein evolution Nov. 10, 2020
-
Patent Title: Diagnostics using conditionally active antibodies Jun. 30, 2020
-
Patent Title: Multi-specific monoclonal antibodies Jun. 30, 2020
-
Patent Title: Comprehensive monoclonal antibody generation Jun. 02, 2020
-
Patent Title: Express humanization of antibodies Feb. 18, 2020
-
Patent Title: Discovering and producing conditionally active biologic proteins in the same eukaryotic cell production hosts Dec. 24, 2019
-
Patent Title: Conditionally active biological proteins Jun. 25, 2019
-
Patent Title: Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts Oct. 23, 2018
-
Patent Title: Methods of protein evolution Oct. 23, 2018
-
Patent Title: Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts Aug. 14, 2018
-
Patent Title: Mirac proteins Jun. 12, 2018
-
Patent Title: Mirac proteins May. 29, 2018
-
Patent Title: Multi-specific monoclonal antibodies May. 15, 2018
-
Patent Title: Anti-cd22 antibodies Jan. 02, 2018
-
Patent Title: Mirac proteins May. 02, 2017
-
Patent Title: Mirac proteins May. 02, 2017
-
Patent Title: Mirac proteins Oct. 11, 2016
-
Patent Title: Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts Oct. 14, 2014
-
Patent Title: Mirac proteins Apr. 29, 2014
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to BCAB
Number of mentions of BCAB in WallStreetBets Daily Discussion
Recent picks made for BCAB stock on CNBC
ETFs with the largest estimated holdings in BCAB
Shareholder
|
Shares Held
|
---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view BCAB Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.